Turconi MG - Search Results

1

Mesenteric and renal oxygen transport during hemorrhage and reperfusion: evaluation of optimal goals for resuscitation.

Chiara O, Pelosi P, Segala M, Turconi MG, Brazzi L, Bottino N, Taccone P, Zambelli M, Tiberio G, Boswell S, Scalea TM. Chiara O, et al. Among authors: turconi mg. J Trauma. 2001 Aug;51(2):356-62. doi: 10.1097/00005373-200108000-00023. J Trauma. 2001. PMID: 11493800

2

Classical corticosteroids and new lipid peroxidation inhibitors in the therapy of multiple organ failure (MOF).

Chiara O, Padalino P, Fattori L, Ravizzini C, Turconi MG, Tiberio G. Chiara O, et al. Among authors: turconi mg. Minerva Chir. 1997 Sep;52(9):1095-102. Minerva Chir. 1997. PMID: 9401356 Review. No abstract available.

3

[Neoplasms of the head and tail of the pancreas].

Tiberio G, De Rai P, Castoldi L, Turconi MG. Tiberio G, et al. Among authors: turconi mg. Ann Ital Chir. 1997 Sep-Oct;68(5):643-7. Ann Ital Chir. 1997. PMID: 9577041 Review. Italian.

4

Synthesis and biological evaluation of new muscarinic receptor antagonists bearing cyclic amidines as cationic heads.

Nicola M, Schiavi GB, Micheletti R, Donetti A, Ladinsky H, Turconi M. Nicola M, et al. Farmaco. 1991 Apr;46(4):539-53. Farmaco. 1991. PMID: 1930552

5

Pharmacological properties of a novel class of 5-HT3 receptor antagonists.

Turconi M, Donetti A, Schiavone A, Sagrada A, Montagna E, Nicola M, Cesana R, Rizzi C, Micheletti R. Turconi M, et al. Eur J Pharmacol. 1991 Oct 15;203(2):203-11. doi: 10.1016/0014-2999(91)90716-4. Eur J Pharmacol. 1991. PMID: 1800117

6

Synthesis of a new class of 2,3-dihydro-2-oxo-1H-benzimidazole-1-carboxylic acid derivatives as highly potent 5-HT3 receptor antagonists.

Turconi M, Nicola M, Quintero MG, Maiocchi L, Micheletti R, Giraldo E, Donetti A. Turconi M, et al. J Med Chem. 1990 Aug;33(8):2101-8. doi: 10.1021/jm00170a009. J Med Chem. 1990. PMID: 1695682

7

Malonamic acid derivatives as M1 selective muscarinic receptor antagonists.

Turconi M, Banfi A, Schiavi GB, Donetti A. Turconi M, et al. Farmaco. 1991 Sep;46(9):999-1009. Farmaco. 1991. PMID: 1807294

8

Antiemetic activity of the new 5-HT3 antagonist DAU 6215 in animal models of cancer chemotherapy and radiation.

Sagrada A, Turconi M, Bonali P, Schiantarelli P, Micheletti R, Montagna E, Nicola M, Algate DR, Rimoldi EM, Donetti A. Sagrada A, et al. Cancer Chemother Pharmacol. 1991;28(6):470-4. doi: 10.1007/BF00685825. Cancer Chemother Pharmacol. 1991. PMID: 1834359

9

Synthesis, absolute configuration, conformational analysis and binding affinity properties of enantiomeric forms of DAU 5750, a novel M1-M3 muscarinic receptor antagonist.

Turconi M, Gozzo A, Schiavi G, Fronza G, Mele A, Bravo P. Turconi M, et al. Bioorg Med Chem. 1994 Dec;2(12):1375-83. doi: 10.1016/s0968-0896(00)82089-1. Bioorg Med Chem. 1994. PMID: 7788300

10

Azabicycloalkyl benzimidazolone derivatives as a novel class of potent agonists at the 5-HT4 receptor positively coupled to adenylate cyclase in brain.

Dumuis A, Sebben M, Monferini E, Nicola M, Turconi M, Ladinsky H, Bockaert J. Dumuis A, et al. Naunyn Schmiedebergs Arch Pharmacol. 1991 Mar;343(3):245-51. doi: 10.1007/BF00251122. Naunyn Schmiedebergs Arch Pharmacol. 1991. PMID: 1650917

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16 results

Search Page

Filters